This review describes preclinical and clinical work that suggests ketogenic therapy may improve schizophrenia symptoms by modulating inflammation, cellular metabolism, and epigenetics. Current evidence is preliminary and requires larger, well-controlled trials.
New Results: First RCT for Schizophrenia & Bipolar Disorder. Learn more.